全文获取类型
收费全文 | 3253篇 |
免费 | 157篇 |
国内免费 | 10篇 |
专业分类
化学 | 2676篇 |
晶体学 | 23篇 |
力学 | 46篇 |
数学 | 293篇 |
物理学 | 382篇 |
出版年
2023年 | 21篇 |
2022年 | 38篇 |
2021年 | 37篇 |
2020年 | 57篇 |
2019年 | 52篇 |
2018年 | 30篇 |
2017年 | 25篇 |
2016年 | 108篇 |
2015年 | 113篇 |
2014年 | 96篇 |
2013年 | 160篇 |
2012年 | 234篇 |
2011年 | 256篇 |
2010年 | 153篇 |
2009年 | 95篇 |
2008年 | 211篇 |
2007年 | 192篇 |
2006年 | 181篇 |
2005年 | 183篇 |
2004年 | 181篇 |
2003年 | 136篇 |
2002年 | 145篇 |
2001年 | 77篇 |
2000年 | 49篇 |
1999年 | 42篇 |
1998年 | 33篇 |
1997年 | 42篇 |
1996年 | 34篇 |
1995年 | 33篇 |
1994年 | 22篇 |
1993年 | 24篇 |
1992年 | 32篇 |
1991年 | 17篇 |
1990年 | 19篇 |
1989年 | 14篇 |
1988年 | 24篇 |
1987年 | 23篇 |
1986年 | 14篇 |
1985年 | 15篇 |
1984年 | 21篇 |
1983年 | 9篇 |
1982年 | 13篇 |
1981年 | 23篇 |
1980年 | 7篇 |
1979年 | 10篇 |
1978年 | 17篇 |
1977年 | 6篇 |
1976年 | 16篇 |
1975年 | 9篇 |
1968年 | 5篇 |
排序方式: 共有3420条查询结果,搜索用时 15 毫秒
81.
Carl F. Brunius Ulrica Edlund Ann‐Christine Albertsson 《Journal of polymer science. Part A, Polymer chemistry》2002,40(21):3652-3661
This work is devoted to the design of a novel family of hydrosoluble biomaterials: poly(N‐vinyl‐2‐pyrrolidone) (PVP)‐based graft copolymers. A synthesis route has been elaborated in which ω‐functionalized PVP is prepared via chain‐transfer radical polymerization, end‐group modified, and subsequently grafted onto a polyhydroxylated backbone, typically dextran or poly(vinyl alcohol). The resulting graft copolymer biomaterials are designed for use in various biomedical applications, particularly as materials with a stronger potential for plasma expansion than already existing products have. The graft copolymers are potentially degradable because the PVP grafts are connected to the polyol backbone via a hydrolytically labile carbonate or ester linkage. The degradation of the graft copolymers was performed in vitro over a period of 6 weeks. © 2002 Wiley Periodicals, Inc. J Polym Sci Part A: Polym Chem 40: 3652–3661, 2002 相似文献
82.
Dupont-Gillain CC Jacquemart I Rouxhet PG 《Colloids and surfaces. B, Biointerfaces》2005,43(3-4):179-186
In the last years, adsorbed collagen was shown to form layers with a supramolecular organization depending on the substrate surface properties and on the preparation procedure. If the concentration of collagen and the duration of adsorption are sufficient, fibrillar collagen structures are formed, corresponding to assemblies of a few molecules. This occurs more readily on hydrophobic compared to hydrophilic surfaces. This study aims at understanding the origin of such fibrillar structures and in particular at determining whether they result from the deposition of fibrils formed in solution or from the building of assemblies at the interface. Therefore, type I collagen solutions with an increasing degree of aggregation were prepared, using the “neutral-start” approach, by ageing pH 5.8 solutions at 37 °C for 15 min, 2 or 7 days. The obtained solutions were used to investigate the influence of collagen aggregation in solution on the supramolecular organization of adsorbed collagen layers, which was characterized by X-ray photoelectron spectroscopy and atomic force microscopy. Polystyrene and plasma-oxidized polystyrene were chosen as substrates for the adsorption. The size and the density of collagen fibrils at the interface decreased upon increasing the degree of aggregation of collagen in solution. This is explained by a competitive adsorption process between monomers and aggregates of the solution, turning at the advantage of the monomers. More aggregated solutions, which are thus depleted in free monomers, behave like less concentrated solutions, i.e. lead to a lower adsorbed amount and less fibril formation at the interface. This study shows that the supramolecular fibrils observed in adsorbed collagen layers, especially on hydrophobic substrates, are not formed in the solution, prior to adsorption, but are built at the interface, through the assembly of free segments of adsorbed molecules. 相似文献
83.
Maria Dalla Pozza Ahmad Abdullrahman Christine J. Cardin Gilles Gasser James P. Hall 《Chemical science》2022,13(35):10193
DNA is a strikingly flexible molecule and can form a variety of secondary structures, including the triple helix, which is the subject of this review. The DNA triplex may be formed naturally, during homologous recombination, or can be formed by the introduction of a synthetic triplex forming oligonucleotide (TFO) to a DNA duplex. As the TFO will bind to the duplex with sequence specificity, there is significant interest in developing TFOs with potential therapeutic applications, including using TFOs as a delivery mechanism for compounds able to modify or damage DNA. However, to combine triplexes with functionalised compounds, a full understanding of triplex structure and chemical modification strategies, which may increase triplex stability or in vivo degradation, is essential – these areas will be discussed in this review. Ruthenium polypyridyl complexes, which are able to photooxidise DNA and act as luminescent DNA probes, may serve as a suitable photophysical payload for a TFO system and the developments in this area in the context of DNA triplexes will also be reviewed.Triplex-forming oligonucleotides can target specific DNA sequences by binding in the duplex major groove. Chemical modifications and ligand binding have been explored, for use in a variety of biological applications. 相似文献
84.
Christine N. Morrison Kathleen E. Prosser Ryjul W. Stokes Anna Cordes Nils Metzler-Nolte Seth M. Cohen 《Chemical science》2022,13(32):9450
Correction for ‘Expanding medicinal chemistry into 3D space: metallofragments as 3D scaffolds for fragment-based drug discovery’ by Christine N. Morrison et al., Chem. Sci., 2020, 11, 1216–1225, https://doi.org/10.1039/C9SC05586J.The authors regret that in the original article, inhibitory values reported for some metallofragments were incorrect. Unfortunately, DMSO stock solutions of reportedly active ferrocene-based metallofragments were found to decompose in the presence of light, which resulted in inaccurate inhibition values. The authors maintain that the core conclusions of the paper are accurate and the utility of three-dimensional metal complexes for fragment-based drug discovery has merit.In the original article, ‘class A’ metallofragments are comprised of ferrocene derivatives (Fig. 1). Some of these ferrocene fragments (specifically those containing carbonyl groups) are reported as broadly inhibiting several protein targets. It was noted in our original report that the ferrocene scaffold was likely promiscuous due to its lipophilicity and potential redox activity, but that it might still serve as a useful metallofragment for fragment-based drug discovery (FBDD) campaigns. However, re-evaluation of these compounds against the influenza endonuclease (PAN) failed to reproduce our original inhibition results for the class A metallofragments using freshly prepared stocks, indicating a problem with the materials used in the original study.Open in a separate windowFig. 1Chemical structures of class A metallofragments.Several compounds from class A were originally reported as having near complete (100%) inhibition against PAN endonuclease at an inhibitor concentration of 200 μM (and2).2). However, when re-evaluated under identical conditions, using freshly prepared DMSO stock solutions, inhibition was only observed with one fragment of this class (A22, Fig. 1), with the previously reported highly active fragments (A4, A7–A21, Compound A1 A2 A3 A4 A5 A7 A8 A9 A10 A11 Reported 12 ± 6 <1 <1 45 ± 14 8 ± 7 103 ± 5 103 ± 4 53 ± 5 46 ± 7 90 ± 5 Corrected 3 ± 10 n.d. 18 ± 3 6 ± 3 21 ± 5 9 ± 3 10 ± 5 4 ± 2 16 ± 4 10 ± 7